用于吸入气雾剂呼吸驱动控制器
呼吸驱动控制器BAC 100i也可以用于呼吸驱动(或呼吸操作)吸入气雾剂的测试。在这种情况下,BAC 100i用于启动流量,同时触发呼吸驱动吸入器。
吸入气雾剂:DDU自动按压测试
Vertus自动震动、喷射和废物抛弃的范围是由精确、受控和可重复的MDI测试的关键集成解决方案组成的。与大多数MDIs兼容,Vertus系统提供分析和整个测试过程的完全控制:
- 驱动前的震动速度、角度和持续时间
- 发射的力量和速度的应用和释放的力量
- 振动结束到设备驱动之间的时间延迟
相关应用程序
我们还提供一系列额外的支持MDI测试应用设备:
省工工具
相关新闻与资源
Copley推出DUSA Shaker™ DTS 100i:成就更快速、更安全、更具可重复性的吸入制剂测试
2023年2月8日;英国诺丁汉 (Nottingham):DUSA Shaker™ DTS 100i是Copley Scientific推出的全新半自动解决方案,公司是吸入制剂及鼻用制剂测试设备的全球领导企业,支持更快速、更高效且符合监管和药典规定的递送剂量均一性 (DDU) 测试。该产品是Copley DUSA振摇器的全新升级版本,可为定量吸入剂 (MDI) 和干粉吸入制剂 (DPI) 的剂量均一性取样装置 (DUSA) 提供全面、快速、可重复的冲洗操作。Copley对吸入制剂的测试理解独到,因此设计坚固的DTS 100i能加快测试进程,提高可重复性和准确性,让分析人员放手去执行价值更高的任务。 通过DDU测试,可以确认单个吸入制剂在整个使用寿命期间以及每批产品的剂量递送的一致性。关键的步骤是冲洗DUSA,使其恢复递送剂量。这一过程可以手动进行,但从确保完全恢复、健康和安全以及效率的角度考虑,自动化方法更加理想。 DTS 100i是一种模块化解决方案,可轻松嵌入任何现有装置或工作流程,而且成本低,是用户体验半自动化优势的理想入门产品。十几年来,独特的DUSA振摇器在全世界忙碌的吸入制剂测试实验室中一直占有一席之地;DTS 100i经过全面的重新设计和更新,可以提供: 与手动操作相比,药物回收速度加快10倍 触摸屏界面直观明了,操作简单 横向振摇和/或旋转运动经过优化,实现可重复的完整冲洗流程 灵活处理满负载或部分负载…
了解详情Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing
14 September 2022; Nottingham, UK: EnviroMate™ is a benchtop environmental control chamber from Copley, the world’s leading manufacturer and supplier of inhaler testing equipment,…
了解详情Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over…
了解详情New e-Training service from Copley for pharmaceutical testing
14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro…
了解详情Copley launches a new webinar series on inhaler testing
20 April 2020; Nottingham, UK: Copley Scientific will shortly begin the company’s inaugural series of technical webinars, offering valuable, easy to understand overviews on…
了解详情Advancing the science of OINDPs: Copley Scientific joins IPAC-RS
28 February 2018; Nottingham, UK: Copley Scientific, a global leader in the design and manufacture of inhaler testing equipment, is pleased to announce that…
了解详情Copley Scientific launches new products for MDI testing in line with the new USP monograph
23 January 2014; Nottingham, UK: Copley Scientific has launched two new products to enable testing in accordance with methods described in a new US…
了解详情Poster: DDL 2022
Investigating the Impact of Electrostatics on Delivered Dose Uniformity for pMDIs Benchtop in vitro testing is vital to characterization of performance of medical aerosols…
了解详情DDD 2021 Respiratory eBook Profile
Semi-Automating Inhaler Testing – A Good Idea, but Where to Start? Cascade impaction is a vital technique in the development and manufacture of orally…
了解详情Q&A: OINDPnews 2022
Reducing Inhaler Testing Variability Through Test Environment Control In this Q&A with OINDPnews, our CEO Mark Copley answers questions about the importance of the…
了解详情American Pharmaceutical Review Article: Nov/Dec 2017
Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing
了解详情PMPS Q&A (Samedan): April 2021
Putting Inhalers to the Test Anna Sipitanou has worked for Copley Scientific for four years, expanding her drug discovery and pharma science background. She…
了解详情Inhalation Article: December 2019
Optimizing the role of automation in variability reduction strategies for delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD) testing of inhaled drug…
了解详情Inhalation Article: April 2019
The regulatory landscape for OINDPs – the biggest shake-up in a generation?
了解详情Drug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
了解详情White Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
了解详情